Screening of Biomarkers Associated with Osteoarthritis Aging Genes and Immune Correlation Studies
Lanwei Xu,Zheng Wang,Gang Wang
DOI: https://doi.org/10.2147/ijgm.s447035
IF: 2.145
2024-01-21
International Journal of General Medicine
Abstract:Lanwei Xu, 1, 2 Zheng Wang, 3 Gang Wang 1 1 Department of Orthopedics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China; 2 Department of Hand and Foot Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, People's Republic of China; 3 Department of Neurosurgery, Liaocheng Traditional Chinese Medicine Hospital, Liaocheng, 252000, People's Republic of China Correspondence: Zheng Wang, Department of Neurosurgery, Liaocheng Traditional Chinese Medicine Hospital, Liaocheng, 252000, People's Republic of China, Tel +86 18063560328, Email Gang Wang, Department of Orthopedics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China, Tel +86 13791006108, Email Purpose: Osteoarthritis (OA) is a joint disease with a long and slow course, which is one of the major causes of disability in middle and old-aged people. This study was dedicated to excavating the cellular senescence-associated biomarkers of OA. Methods: The Gene Expression Omnibus (GEO) database was searched and five datasets pertaining to OA were obtained. After removing the batch effect, the GSE55235, GSE55457, GSE82107, and GSE12021 datasets were integrated together for screening of the candidate genes by differential analysis and weighted gene co-expression network analysis (WGCNA). Next, those genes were further filtered by machine learning algorithms to obtain cellular senescence-associated biomarkers of OA. Subsequently, enrichment analyses based on those biomarkers were conducted, and we profiled the infiltration levels of 22 types immune cells with the ERSORT algorithm. A lncRNA-miRNA-mRNA regulatory and drug-gene network were constructed. Finally, we validated the senescence-associated biomarkers at both in vivo and in vitro levels. Results: Five genes (BCL6, MCL1, SLC16A7, PIM1, and EPHA3) were authenticated as cellular senescence-associated biomarkers in OA. ROC curves demonstrated the reliable capacity of the five genes as a whole to discriminate OA samples from normal samples. The nomogram diagnostic model based on 5 genes proved to be a reliable predictor of OA. Single-gene GSEA results pointed to the involvement of the five biomarkers in immune-related pathways and oxidative phosphorylation in the development of OA. Immune infiltration analysis manifested that the five genes were significantly correlated with differential immune cells. Subsequently, a lncRNA-miRNA-mRNA network and gene-drug network containing were generated based on five cellular senescence-associated biomarkers in OA. Conclusion: A foundation for understanding the pathophysiology of OA and new insights into OA diagnosis and treatment were provided by the identification of five genes, namely BCL6, MCL1, SLC16A7, PIM1, and EPHA3, as biomarkers associated with cellular senescence in OA. Keywords: osteoarthritis, cellular senescence-related genes, biomarkers, drugs, PIM1 Osteoarthritis is a common degenerative joint disease of the middle-aged and elderly, with about 3 million new cases diagnosed each year. 1 The disease is a progressive, chronic disease that is characterized by damage to the cartilage of the joints and involves the entire joint tissue, manifesting itself in joint pain, stiffness, hypertrophy, and restricted movement, and is one of the main causes of disability in the middle-aged and elderly, and places a severe psychological, financial and physical burden on patients. 2,3 The pathological features of OA include degeneration of articular cartilage, narrowing of the joint space, inflammation of the synovial membrane, formation of bone fragments and alteration of mechanical properties. 4–6 Osteoarthritis is a comprehensive joint disease encompassing all joint tissues with risk factors including joint injury, poor joint development, genetics, age, obesity and gender. 7–9 Conventional diagnostic methods, including the combination of clinical presentation, physical examination, and imaging techniques like X-ray, are inadequate for the early detection of osteoarthritis. 10–12 Because of the difficulty of early diagnosis, most patients have limited treatment options, leading to poor prognoses. Screening of early biomarkers using bioinformatics has attracted the attention of researchers, developing early biomarkers of OA for disease diagnosis and providing therapeutic targets is of great significance. 13–15 Cell aging is one of the signs of aging and a kind of cell fate. 16 Cellular senescence is characterized by cell cycle arrest and releasing harmful pro-inflammatory molecules into the pericellular microenvironment.<su -Abstract Truncated-
medicine, general & internal